Location History:
- Watchtberg, DE (2017)
- Wachtberg, DE (2017)
Company Filing History:
2 out of 5 
1 out of 30 
1 out of 3 Years Active: 2017
Title: Anja Wieland: Innovator in Cancer Treatment
Introduction
Anja Wieland is a prominent inventor based in Munich, Germany, known for her significant contributions to cancer treatment through innovative therapeutic methods. With a total of two patents, her work focuses on the development of novel compounds aimed at combating solid tumors and glioblastoma.
Latest Patents
Wieland's latest patents include "Niclosamide and its derivatives for use in the treatment of solid tumors." This invention explores the therapeutic uses of niclosamide, particularly in combination with alkylating agents for treating solid tumors characterized by underexpression of NFKBIA. Additionally, it outlines diagnostic methods to determine the suitability of niclosamide treatment for cancer patients. Another notable patent is "Glioblastoma inhibiting compounds and their use," which relates to the use of gambogic acid amide and its derivatives for treating glioblastoma. This patent also includes methods for assessing the appropriateness of these compounds for individual patients.
Career Highlights
Throughout her career, Anja Wieland has worked with esteemed organizations such as Life & Brain GmbH and Rheinische Friedrich-Wilhelms-Universität Bonn. Her experience in these institutions has allowed her to collaborate with leading experts in the field of cancer research.
Collaborations
Wieland has collaborated with notable colleagues, including Björn Scheffler and Martin Glas, contributing to the advancement of cancer treatment methodologies.
Conclusion
Anja Wieland's innovative work in cancer treatment exemplifies her dedication to improving patient outcomes through her patented inventions. Her contributions to the field continue to inspire advancements in therapeutic approaches for challenging diseases.